UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials

Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology. (Carolina Alumni Review)

Related: Campus Connections

Comedian, UNC alum Lewis Black returns to alma mater for final tour
Now 76, Lewis Black is embarking on “Goodbye Yeller Brick Road, The Final Tour.” Fittingly, the tour will bring Black back to the same town...
Sun Apr 27, 2025

Remembering Carl Boettcher, UNC carver and WWI emigre
Pieces of UNC’s history remain throughout campus, and some were created by a man who came to the United States for a better life. A...
Fri Apr 25, 2025

Chansky’s Notebook: Wide World of Sports
Jim Lampley’s memoir is out, and it really did happen. We had the official launch party Tuesday night at the Chapel Hill Country Club for...
Wed Apr 23, 2025

Spring at Carolina
Spring is in the air at the University of North Carolina, and the warmer temperatures bring plenty of favorite University traditions. Nothing feels more like...
Tue Apr 22, 2025